5XJ3 | date | ![]() |
|||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
authors | |||||||||||||||
compound | source | ||||||||||||||
symmetry |
| ||||||||||||||
crystal cell |
| ||||||||||||||
method | X-Ray Diffraction | resolution | |||||||||||||
Gene Ontology ![]() |
| ||||||||||||||
Primary reference | Remarkably similar CTLA-4 binding properties of therapeutic ipilimumab and tremelimumab antibodies., He M, Chai Y, Qi J, Zhang CWH, Tong Z, Shi Y, Yan J, Tan S, Gao GF, Oncotarget. 2017 May 19;8(40):67129-67139. doi: 10.18632/oncotarget.18004., eCollection 2017 Sep 15. PMID:28978021 |
Data retrieval |
![]() |
View 5XJ3 in 3D |
![]() |
Structure-derived information |
Sequence-derived information |
OCA© by Jaime Prilusky, 1996-2014,2022,2024 Bioinformatics Unit Weizmann Institute of Science |